Am J Perinatol 2012; 29(03): 153-158
DOI: 10.1055/s-0031-1284224
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Relationship between Maternal Body Mass Index and Tobacco Use on Small-for-Gestational-Age Infants

Katherine R. Goetzinger
1   Department of Obstetrics and Gynecology, Washington University, St. Louis, Missouri
,
Alison G. Cahill
1   Department of Obstetrics and Gynecology, Washington University, St. Louis, Missouri
,
George A. Macones
1   Department of Obstetrics and Gynecology, Washington University, St. Louis, Missouri
,
Anthony O. Odibo
1   Department of Obstetrics and Gynecology, Washington University, St. Louis, Missouri
› Author Affiliations
Further Information

Publication History

01 February 2011

26 April 2011

Publication Date:
22 July 2011 (online)

Abstract

We sought to estimate the association between prepregnancy body mass index (BMI) and small-for-gestational-age (SGA) neonates and to determine if there is a synergistic effect of tobacco use on SGA across all BMI strata. We performed a retrospective cohort study of 65,104 patients seen for second-trimester ultrasound. BMI was categorized into underweight, normal weight, overweight, and obese. SGA was defined as birth weight <10th percentile and <5th percentile. Univariable and multivariable logistic regression analyses were used to evaluate the association between BMI and SGA. Stratified analyses and tests for effect modification were performed to evaluate for a potential synergistic effect between tobacco use and abnormal prepregnancy BMI on SGA. After controlling for potential confounders, underweight BMI was associated with an increased risk for SGA <10th percentile (adjusted odds ratio [aOR] 1.8, 95% confidence interval [CI] 1.5 to 2.1), while overweight (aOR 0.7, 95% CI 0.7 to 0.8) and obese BMIs (aOR 0.6, 95% CI 0.5 to 0.7) were associated with a decreased risk of SGA. There was no effect modification of tobacco use on the risk of SGA across all BMI categories. Although both tobacco and underweight BMI are independently associated with SGA, there was no evidence of synergism. Continued emphasis on both smoking cessation and maintenance of normal prepregnancy BMI remains paramount to decreasing the incidence of SGA.

 
  • References

  • 1 Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol 2005; 192: 1856-1862, discussion 1862–1863
  • 2 Bernstein IM, Plociennik K, Stahle S, Badger GJ, Secker-Walker R. Impact of maternal cigarette smoking on fetal growth and body composition. Am J Obstet Gynecol 2000; 183: 883-886
  • 3 Ehrenberg HM, Dierker L, Milluzzi C, Mercer BM. Low maternal weight, failure to thrive in pregnancy, and adverse pregnancy outcomes. Am J Obstet Gynecol 2003; 189: 1726-1730
  • 4 Doherty DA, Magann EF, Francis J, Morrison JC, Newnham JP. Pre-pregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet 2006; 95: 242-247
  • 5 American College of Obstetricians and Gynecologists. Intrauterine growth restriction. ACOG Practice Bulletin #12. Washington, DC: ; American College of Obstetricians and Gynecologists, 2000
  • 6 Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69: 1-7
  • 7 Aagaard-Tillery KM, Porter TF, Lane RH, Varner MW, Lacoursiere DY. In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am J Obstet Gynecol 2008; 198: 66-e1–e6
  • 8 Cnattingius S, Bergström R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; 338: 147-152
  • 9 Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004; 103: 219-224
  • 10 Gardosi J, Francis A. A customized standard to assess fetal growth in a US population. Am J Obstet Gynecol 2009; 201: 25, e1-e7
  • 11 McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312: 82-90
  • 12 Barker DJP. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49: 270-283
  • 13 Ness RB, Zhang J, Bass D, Klebanoff MA. Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth. Am J Epidemiol 2008; 168: 427-433
  • 14 Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87: 163-168
  • 15 Kelly SJ, Lilley JM, Leonardi-Bee J. Associations of morbidity in the underweight. Eur J Clin Nutr 2010; 64: 475-482
  • 16 Park E. Gender as a moderator in the association of body weight to smoking and mental health. Am J Public Health 2009; 99: 146-151
  • 17 Dicke JM, Blanco VM, Yan Y, Coplen DE. The type and frequency of fetal renal disorders and management of renal pelvis dilatation. J Ultrasound Med 2006; 25: 973-977
  • 18 Goetzinger KR, Stamilio DM, Dicke JM, Macones GA, Odibo AO. Evaluating the incidence and likelihood ratios for chromosomal abnormalities in fetuses with common central nervous system malformations. Am J Obstet Gynecol 2008; 199: 285, e1-e6
  • 19 Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 2004; 6 (Suppl 2) S125-S140